The clinical radiobiology of brachytherapy

被引:109
作者
Dale, RG [1 ]
Jones, B
机构
[1] Charing Cross Hosp, Hammersmith Hosp NHS Trust, London W6 8RF, England
[2] Clatterbridge Ctr Oncol, Wirral L63 4JY, Merseyside, England
关键词
D O I
10.1259/bjr.71.845.9691890
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The unique geometrical features of brachytherapy, together with the wide variety of temporal patterns of dose delivery, result in important interactions between physics and radiobiology. These interactions exert a major influence on the way in which brachytherapy treatments should be evaluated, both in absolute and comparative terms. This article reviews the main physical and radiobiological aspects of brachytherapy and considers examples of their influence on specific types of treatment. The issues relating to the optimization of high dose rate brachytherapy are presented, together with the implications of multiphasic repair kinetics for low dose-rate and pulsed high dose rate brachytherapy. The opportunities for application of radiobiological principles to improve various brachytherapy techniques, together with the integration of brachytherapy with teletherapy, are also outlined. Equations for the numerical evaluation of brachytherapy treatments are presented in the Appendices.
引用
收藏
页码:465 / 483
页数:19
相关论文
共 151 条
[1]   REDOX, RADIATION, AND REDUCTIVE BIOACTIVATION [J].
ADAMS, GE .
RADIATION RESEARCH, 1992, 132 (02) :129-139
[2]   A NATURAL VOLUME-DOSE HISTOGRAM FOR BRACHYTHERAPY [J].
ANDERSON, LL .
MEDICAL PHYSICS, 1986, 13 (06) :898-903
[3]   IMPACT OF SPINAL-CORD REPAIR KINETICS ON THE PRACTICE OF ALTERED FRACTIONATION SCHEDULES [J].
ANG, KK ;
JIANG, GL ;
GUTTENBERGER, R ;
THAMES, HD ;
STEPHENS, LC ;
SMITH, CD ;
FENG, Y .
RADIOTHERAPY AND ONCOLOGY, 1992, 25 (04) :287-294
[4]  
[Anonymous], 1987, FRACTIONATION RADIOT
[5]  
Badie C, 1996, INT J RADIAT BIOL, V70, P563, DOI 10.1080/095530096144761
[6]   TOPICAL INFUSION OF METRONIDAZOLE IN THE RADIOTHERAPY OF TUMORS OF THE UTERINE CERVIX - INTERIM-REPORT ON THE 2 YEAR SURVIVAL [J].
BALMUKHANOV, SB ;
BEISEBAEV, AA ;
MUSTAPHIN, DS ;
AITKOLOVA, ZK ;
KOBIKOVA, DH ;
ABDRAHMANOV, DN ;
SCOTT, OCA ;
REVESZ, L .
BRITISH JOURNAL OF RADIOLOGY, 1990, 63 (750) :499-500
[7]   INTRATUMORAL AND PARAMETRIAL INFUSION OF METRONIDAZOLE IN THE RADIOTHERAPY OF UTERINE CERVIX CANCER - PRELIMINARY-REPORT [J].
BALMUKHANOV, SB ;
BEISEBAEV, AA ;
AITKOOLOVA, ZI ;
MUSTAPHIN, JS ;
PHILIPPENKO, VI ;
RISMUHAMEDOVA, RS ;
AISAROVA, AM ;
ABDRAHMANOV, JN ;
REVESZ, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (04) :1061-1063
[8]   DOSE FRACTIONATION, DOSE-RATE AND ISO-EFFECT RELATIONSHIPS FOR NORMAL TISSUE RESPONSES [J].
BARENDSEN, GW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11) :1981-1997
[9]   COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY [J].
BERGH, J ;
NORBERG, T ;
SJOGREN, S ;
LINDGREN, A ;
HOLMBERG, L .
NATURE MEDICINE, 1995, 1 (10) :1029-1034
[10]   APOPTOTIC CELL-DEATH INDUCED BY C-MYC IS INHIBITED BY BCL-2 [J].
BISSONNETTE, RP ;
ECHEVERRI, F ;
MAHBOUBI, A ;
GREEN, DR .
NATURE, 1992, 359 (6395) :552-554